PRANATHI MRUTHYUNJAYA: Open Payments
NPI 1144636705 · SANTA CRUZ, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$280 in 9 payments from 5 companies in 2025. Trend: 2023 $114 · 2024 $167 · 2025 $280
Food & beverage: $280
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $102 |
| E.R. Squibb & Sons, L.L.C. | 3 | $82 |
| Janssen Pharmaceuticals, Inc | 1 | $51 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $28 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $17 |
Products named: COBENFY, ABILIFY ASIMTUFII, INVEGA SUSTENNA, CAPLYTA, ABILIFY MAINTENA.
Industry payments across CA — which companies pay providers there.
